Cronos Group (NASDAQ:CRON) Shares Cross Below 50 Day Moving Average – What’s Next?

Cronos Group Inc. (NASDAQ:CRON – Get Free Report) crossed below its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $3.32 and traded as low as $3.25. Cronos Group shares last traded at $3.27, with a volume of 911,176 shares trading hands.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on CRON shares. Weiss Ratings raised shares of Cronos Group from a “buy (b-)” rating to a “buy (b)” rating in a report on Thursday, October 8th. Wall Street Zen upgraded Cronos Group from a “hold” rating to a “buy” rating in a research report on Saturday, November 7th. Zacks Research raised Cronos Group from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 22nd. Finally, TD Securities reaffirmed a “buy” rating on shares of Cronos Group in a research report on Monday, September 28th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $2.30.

Get Our Latest Stock Report on Cronos Group

Cronos Group Stock Down 0.6%

The business has a fifty day simple moving average of $3.32 and a two-hundred day simple moving average of $2.90. The company has a market cap of $1.16 billion, a P/E ratio of 39.88 and a beta of 0.96.

Cronos Group (NASDAQ:CRON – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported $0.04 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.01. Cronos Group had a net margin of 28.04% and a return on equity of 2.56%. The business had revenue of $63.45 million for the quarter, compared to the consensus estimate of $51.15 million. On average, equities analysts predict that Cronos Group Inc. will post 0.16 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in CRON. Goldman Sachs Group Inc. lifted its stake in shares of Cronos Group by 23.5% during the 3rd quarter. Goldman Sachs Group Inc. now owns 671,031 shares of the company’s stock valued at $2,214,000 after buying an additional 127,795 shares in the last quarter. Jump Financial LLC bought a new position in shares of Cronos Group in the third quarter worth about $234,000. State Street Corp purchased a new stake in shares of Cronos Group during the third quarter worth about $404,000. Private Advisor Group LLC grew its position in shares of Cronos Group by 10.0% during the third quarter. Private Advisor Group LLC now owns 32,681 shares of the company’s stock worth $108,000 after purchasing an additional 2,984 shares in the last quarter. Finally, HighTower Advisors LLC bought a new stake in Cronos Group during the 3rd quarter valued at approximately $1,198,000. 8.71% of the stock is owned by hedge funds and other institutional investors.

Cronos Group Company Profile

(Get Free Report)

Cronos Group is a cannabinoid company that develops, produces, and markets cannabis and cannabis-derived products. Its business includes cultivation, processing, product development, and distribution. The company sells products in categories such as dried cannabis flower, pre-rolls, vaporizers, edibles, and extracts. Its brand portfolio includes Spinach and PEACE NATURALS. Founded in 2012 and headquartered in Toronto, Cronos serves consumers in Canada and select international markets, including Israel.

Featured Articles

Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.